Insider · CIK 0001460212
Andrew J. Mills
Files at MDLN (Medline Inc.). First filing Dec 22, 2025, latest Dec 22, 2025.
In brief
Andrew J. Mills files SEC Form 4 as director at MDLN (Medline Inc.). Since Dec 22, 2025, Andrew J. Mills has reported 1 open-market buy worth $75M and 0 open-market sells worth $0, the latest filed on Dec 22, 2025.
A track record needs three past buys with six months of prices behind them; Andrew J. Mills has 0, so none is measured yet.
The newest scored trade: bought $75M of MDLN on Dec 18, 2025, filed Dec 22, 2025, scored 73 (notable). In the last 12 months: 1 buy worth $75M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MDLN: Medline Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 73Notable | Medline Inc. | $75M 2,586,206 shares | - | 0% from low-4% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Class B Common Stockindirect: See Footnote | +30,655 | - | - | 30,655 | Dec 22, 2025 |
| Dec 18, 2025 | MDLN Medline Inc. | POpen-market purchase Class A Common Stockindirect: See Footnote | +2,586,206 | $29.00 | $75M | 2,586,206 | Dec 22, 2025 |
| Dec 16, 2025 | MDLN Medline Inc. | AGrant or award Common Units of Medline Holdings, LPderivativeindirect: See Footnote | +30,655 | - | - | 30,655 | Dec 22, 2025 |
Questions about Andrew J. Mills
Answered from the filings on this page, as of the latest one.
Is Andrew J. Mills buying or selling?
In the last 12 months Andrew J. Mills reported 1 open-market buy worth $75M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $75M of MDLN on Dec 18, 2025. Grants, option exercises and tax withholding are not counted.
How did Andrew J. Mills's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Andrew J. Mills has 0.
Where does Andrew J. Mills file Form 4?
Andrew J. Mills has filed Form 4 at MDLN (Medline Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.